Internal Medicine, Hematology & Oncology · Huntsville, AL
NPI
1336303940
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3601 Cci Dr NW
Huntsville, AL, 35805
Phone (256) 705-4224
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.7M
216,117 services
Medicare patients, 2024
1,028
Average age 75
Drug cost, 2024
$5.3M
2,445 prescriptions
Company payments, 2025
$2,823
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lakshmikanth Katragadda was code J9271 (injection, pembrolizumab, 1 mg), 27,600 times for 30 patients. In total Lakshmikanth Katragadda billed 216,117 services in 211 codes, and Medicare paid $5.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 27,600 | 30 | $44.65 | $1.2M |
| J0897 Injection, denosumab, 1 mg | Office | 9,180 | 65 | $20.41 | $187K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,904 | 16 | $0.08 | $467 |
| J0185 Injection, aprepitant, 1 mg | Office | 5,460 | 14 | $1.35 | $7,358 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,120 | 16 | $36.93 | $152K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 3,585 | 18 | $2.29 | $8,206 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 3,420 | 11 | $39.05 | $134K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,020 | 67 | $0.09 | $262 |
| 85025 Blood Count | Office | 2,301 | 857 | $7.56 | $17K |
| 80053 Clinical Chemistry | Office | 2,224 | 849 | $10.28 | $23K |
| 36415 Venipuncture Blood Collection | Office | 2,177 | 847 | $8.63 | $19K |
| J1750 Injection, iron dextran, 50 mg | Office | 1,934 | 80 | $13.51 | $26K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,219 | 73 | $0.23 | $275 |
| 82728 Clinical Chemistry | Office | 1,147 | 589 | $13.22 | $15K |
| 83550 Clinical Chemistry | Office | 1,145 | 586 | $8.47 | $9,699 |
By year: 2022 $4.8M for 220,882 services; 2023 $5.2M for 235,960 services; 2024 $5.7M for 216,117 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,301 | 857 | $7.56 | $17K |
| 80053 Clinical Chemistry | 2,224 | 849 | $10.28 | $23K |
| 36415 Venipuncture Blood Collection | 2,177 | 847 | $8.63 | $19K |
| 82728 Clinical Chemistry | 1,147 | 589 | $13.22 | $15K |
| 83550 Clinical Chemistry | 1,145 | 586 | $8.47 | $9,699 |
| 83540 Clinical Chemistry | 1,145 | 586 | $6.27 | $7,183 |
| 82607 Clinical Chemistry | 1,096 | 558 | $14.61 | $16K |
| 82746 Clinical Chemistry | 967 | 496 | $14.23 | $14K |
| 83615 Clinical Chemistry | 952 | 491 | $5.87 | $5,584 |
| 85046 Blood Count | 930 | 497 | $5.39 | $5,012 |
Medicare prescription drug claims, 2024
In 2024, the drug Lakshmikanth Katragadda prescribed most often to Medicare patients was Anastrozole, with 219 prescriptions and refills. In total Lakshmikanth Katragadda wrote 2,445 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 219 | 452 | 60 | $3,905 |
| Eliquis Apixaban | 202 | 288 | 55 | $163K |
| Oxycodone Hcl Generic | 85 | 85 | 23 | $1,794 |
| Ondansetron Odt Ondansetron | 85 | 90 | 58 | $3,259 |
| Xarelto Rivaroxaban | 81 | 106 | 15 | $56K |
| Exemestane Generic | 72 | 122 | 19 | $8,099 |
| Duloxetine Hcl Generic | 70 | 116 | 23 | $854 |
| Pantoprazole Sodium Generic | 67 | 124 | 36 | $384 |
| Gabapentin Generic | 64 | 74 | 21 | $734 |
| Mirtazapine Generic | 60 | 78 | 27 | $348 |
| Levothyroxine Sodium Generic | 55 | 78 | 15 | $257 |
| Valacyclovir Valacyclovir Hcl | 54 | 84 | 14 | $1,757 |
| Hydroxyurea Generic | 52 | 106 | 16 | $1,678 |
| Prochlorperazine Maleate Generic | 51 | 57 | 37 | $1,299 |
| Xtandi Enzalutamide | 45 | 45 | Under 11 | $579K |
Brand drugs: 764 claims; generic drugs: 1,681 claims; opioid claims: 218.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lakshmikanth Katragadda $2,823 ($2,823 in general payments such as food, travel and fees) from 36 companies. The largest payer was Genzyme Corporation with $424.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 4 | $424 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $174 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $171 |
| GlaxoSmithKline, LLC. GSK | 3 | $162 |
| Secura Bio, Inc. | 2 | $162 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $158 |
| Blueprint Medicines Corporation SNY | 2 | $142 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $138 |
| Pfizer Inc. PFE | 8 | $137 |
| Incyte Corporation INCY | 9 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.